587 related articles for article (PubMed ID: 27027811)
1. Management of connective tissue diseases associated interstitial lung disease: a review of the published literature.
Wallace B; Vummidi D; Khanna D
Curr Opin Rheumatol; 2016 May; 28(3):236-45. PubMed ID: 27027811
[TBL] [Abstract][Full Text] [Related]
2. Management of interstitial lung disease associated with connective tissue disease.
Mathai SC; Danoff SK
BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
[TBL] [Abstract][Full Text] [Related]
3. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM
Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061
[TBL] [Abstract][Full Text] [Related]
4. Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases.
Saketkoo LA; Mittoo S; Frankel S; LeSage D; Sarver C; Phillips K; Strand V; Matteson EL; ;
J Rheumatol; 2014 Apr; 41(4):792-8. PubMed ID: 24488412
[TBL] [Abstract][Full Text] [Related]
5. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
6. The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease.
Yamakawa H; Ogura T; Sato S; Nishizawa T; Kawabe R; Oba T; Kato A; Horikoshi M; Akasaka K; Amano M; Kuwano K; Sasaki H; Baba T; Matsushima H
Respir Med; 2020 Oct; 172():106125. PubMed ID: 32911135
[TBL] [Abstract][Full Text] [Related]
7. Assessment and management of connective tissue disease-associated interstitial lung disease.
Fischer A; Chartrand S
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):2-21. PubMed ID: 26237351
[TBL] [Abstract][Full Text] [Related]
8. Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.
Koo SM; Uh ST
Korean J Intern Med; 2017 Jul; 32(4):600-610. PubMed ID: 28704913
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.
Vij R; Strek ME
Chest; 2013 Mar; 143(3):814-824. PubMed ID: 23460159
[TBL] [Abstract][Full Text] [Related]
10. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
[TBL] [Abstract][Full Text] [Related]
11. Rituximab for the treatment of connective tissue disease-associated interstitial lung disease.
Chartrand S; Swigris JJ; Peykova L; Fischer A
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):296-304. PubMed ID: 26847096
[TBL] [Abstract][Full Text] [Related]
12. Management of connective tissue disease-associated interstitial lung disease.
Chartrand S; Fischer A
Rheum Dis Clin North Am; 2015 May; 41(2):279-94. PubMed ID: 25836643
[TBL] [Abstract][Full Text] [Related]
13. Interstitial lung disease in systemic sclerosis.
Bussone G; Mouthon L
Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
[TBL] [Abstract][Full Text] [Related]
14. Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study.
Sambataro G; Libra A; Spicuzza L; Palmucci S; Conti P; Spagnolo E; Colaci M; Malatino L; Orlandi M; Sambataro D; Vancheri C
Respiration; 2023; 102(6):405-415. PubMed ID: 37231870
[TBL] [Abstract][Full Text] [Related]
15. Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements.
Kuwana M; Bando M; Kawahito Y; Sato S; Suda T; Kondoh Y;
Expert Rev Respir Med; 2023 Jan; 17(1):71-80. PubMed ID: 36786105
[TBL] [Abstract][Full Text] [Related]
16. New treatment paradigms for connective tissue disease-associated interstitial lung disease.
Kouranos V; Miranda G; Corte TJ; Renzoni EA
Curr Opin Pulm Med; 2018 Sep; 24(5):453-460. PubMed ID: 30020142
[TBL] [Abstract][Full Text] [Related]
17. Determining respiratory impairment in connective tissue disease-associated interstitial lung disease.
Assayag D; Ryerson CJ
Rheum Dis Clin North Am; 2015 May; 41(2):213-23. PubMed ID: 25836638
[TBL] [Abstract][Full Text] [Related]
18. Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group.
Khanna D; Mittoo S; Aggarwal R; Proudman SM; Dalbeth N; Matteson EL; Brown K; Flaherty K; Wells AU; Seibold JR; Strand V
J Rheumatol; 2015 Nov; 42(11):2168-71. PubMed ID: 25729034
[TBL] [Abstract][Full Text] [Related]
19. The correlation between miR-200c and the severity of interstitial lung disease associated with different connective tissue diseases.
Jiang Z; Tao JH; Zuo T; Li XM; Wang GS; Fang X; Xu XL; Li XP
Scand J Rheumatol; 2017 Mar; 46(2):122-129. PubMed ID: 27309544
[TBL] [Abstract][Full Text] [Related]
20. Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease.
Mulcaire-Jones E; Pugashetti JV; Oldham JM; Khanna D
Semin Respir Crit Care Med; 2024 Jun; 45(3):435-448. PubMed ID: 38740369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
